Xtant Medical Holdings, Inc. Common Stock
Key Metrics
Market Snapshot
About
Xtant Medical Holdings, Inc. Common Stock (XTNT) is a medical technology company headquartered in Belgrade, Montana. It develops regenerative medicine products and medical devices used by orthopedic and neurological surgeons, serving customers in the United States and internationally. The company is known for its range of bone graft materials and spinal implant systems.
A large part of the business centers on regenerative products derived from human tissue. Its offerings include OsteoSponge, a natural scaffold that supports cellular in-growth, and several demineralized bone matrix putties such as OsteoSelect and OsteoSelect PLUS. The 3Demin family of allografts is designed to support bone healing, while products like OsteoFactor Pro and OsteoVive Plus use processed allograft bone. The company also supplies nanOss products built around nano-structured hydroxyapatite, sports allografts for ligament and meniscal repair, milled spinal allografts, and traditional allografts for applications spanning orthopedics, neurology, podiatry, oral and maxillofacial surgery, and reconstructive procedures.
Xtant also makes a broad set of spinal hardware. This includes cervical products such as the Spider plating, Streamline OCT, and CervAlign systems, along with thoracolumbar systems like Axle-X, Streamline MIS and TL fixation, and HPS 2.0. Its lineup further covers Silex sacroiliac joint fusion systems, interbody implants including Calix, Irix, and Fortilink, the Contact anterior lumbar plate, and interlaminar stabilization products such as the Coflex device and CoFix implants. Xtant Medical Holdings, Inc. earns revenue by supplying these biologic and device products to surgeons performing spinal and orthopedic procedures.